Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine versus cisplatin + gemcitabine in advanced biliary tract tumors
ISRCTN96194255Phase 2Completed
- Sponsor
- The Christie
- Start
- Jan 2002
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial in biliary cancer, cholangiocarcinoma (CCA), gallbladder cancer and 1 more comparing Gemcitabine monotherapy with Cisplatin + gemcitabine (2 arms). Primary endpoint: 6-month progression-free rate. Started Jan 2002; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
biliary cancercholangiocarcinoma (CCA)gallbladder cancerAmpullary cancer (AC)
Beyond the preview
Go deeper on ISRCTN96194255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96194255.